2-(2-Chloro-5-nitrophenoxy)acetic acid, 98%, 2.5g

2-Methoxy-5-methylbenzoic acid, 95.0%, 500g

4,4,5,5-Tetramethyl-2-(2,3,5,6-tetramethylphenyl)-1,3,2-dioxaborolane, 98%, 100mg

Methyl 2-amino-5-bromo-4-(trifluoromethyl)benzoate, 98%, 100mg

Sodium 2-(4-((2-oxocyclopentyl)methyl)phenyl)propanoate, 95.0%, 500g

N-methyl-1-(2-phenyl-1,3-thiazol-5-yl)methanamine - malonic acid (1:1), 95.0%, 5g

(E)-3-((1H-Indol-3-yl)methylene)-5-((E)-3,4-dimethoxybenzylidene)-1-methylpiperidin-4-one, 99.0%, 250mg

N-(1-(4-CHLORO-3-FLUOROPHENYL)-2-METHYLPROPAN-2-YL)ACETAMIDE, 95.0%, 1g

2-Chloro-6-ethoxypyridin-4-amine, 95+%, 500mg

ethyl 2-(4-bromophenyl)ethanecarboximidate hydrochloride, 95.0%, 2g

1-(4-Hydroxyphenyl)propan-2-one, 98.0%, 25g

Anti-alpha2-6-Sialylated 6-sulfo LacNAc Monoclonal Antibody (KN343)1vial

3-(3-piperidinyl)propanamide hydrochloride, 95.0%, 10g